4-氧代-1,4-二氢苯并[h]喹啉-3-羧酸 | 51726-83-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 4-氧代-1,4-二氢苯并[h]喹啉-3-羧酸
• 英文名称: 4-oxo-1,4-dihydrobenzo[h]quinoline-3-carboxylic acid
• 英文别名: Spec-2；4-oxo-1H-benzo[h]quinoline-3-carboxylic acid
• CAS: 51726-83-1
• 化学式: C₁₄H₉NO₃
• 分子量: 239.23
• InChiKey: QGOKEDVMXJBTAR-UHFFFAOYSA-N

物化性质

• 沸点：
  458.4±45.0 °C(Predicted)
• 密度：
  1.437±0.06 g/cm3(Predicted)
• 溶解度：
  DMF：0.1 mg/ml；二甲基亚砜：0.2 mg/ml

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-氧代-1,4-二氢苯并[h]喹啉-3-羧酸 在 五氯化磷 、 三氯氧磷 作用下， 生成 4-chlorobenzquinoline
  参考文献：
  名称：

  Foster et al., Journal of the American Chemical Society, 1946, vol. 68, p. 1327,1330

  摘要：

  DOI：
• 作为产物：
  描述：

  4-羟基苯并[h]喹啉-3-羧酸乙酯 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 5.0h， 以40%的产率得到4-氧代-1,4-二氢苯并[h]喹啉-3-羧酸
  参考文献：
  名称：

  新型喹诺酮-3-羧酸衍生物作为抗HIV-1药物：设计，合成和生物活性

  摘要：

  合成了一系列新的喹诺酮-3-羧酸，它们在N-1，C-2，C-7和C-8位置具有不同的疏水基团，并评估了它们对单周期可复制HIV NL4-3的抑制作用Hela细胞培养物中p 24的表达速率。大多数合成的化合物在100μM的浓度下均具有抗HIV活性，且无明显的细胞毒性。活性最高的化合物4h，4k和4j表现出抗HIV活性，抑制率分别为55％，71％和84％。使用可用于PFV整合酶的晶体学数据（包括其与Mg 2+的配合物）进行的对接研究Raltegravir和Raltegravir揭示，活性化合物可以在Raltegravir附近占据相同的空间，并与活性位点中的Mg 2 +离子相互作用。因此，合成化合物的抗HIV活性可能涉及金属螯合机制。

  DOI：

  10.1007/s00044-016-1631-x

文献信息

• The inhibition of factor inhibiting hypoxia-inducible factor (FIH) by β-oxocarboxylic acids
  作者：Biswadip Banerji、Ana Conejo-Garcia、Luke A. McNeill、Michael A. McDonough、Matthew R. G. Buck、Kirsty S. Hewitson、Neil J. Oldham、Christopher J. Schofield

  DOI：10.1039/b510707e

  日期：——

  Cyclic β-oxocarboxylic acids inhibit factor inhibiting hypoxia-inducible factor via ligation to the active site iron.

  环状β-氧羰基酸通过结合到活性位点铁而抑制缺氧诱导因子抑制因子。
• Benzo(h)quinoline derivatives as G-quadruplex binding agents
  作者：Hanumantharao Paritala、Steven M. Firestine

  DOI：10.1016/j.bmcl.2009.02.016

  日期：2009.3

  G-quadruplexes are unusual structures formed from guanine-rich sequences of nucleic acids. G-quadruplexes have been postulated to play important roles in a number of biological systems including gene regulation and the inhibition of enzyme function. Recently, our laboratory reported on the synthesis and evaluation of a triaza-cyclopentaphenanthrene compound which bound to G-quadruplexes with good affinity

  G-四链体是由富含鸟嘌呤的核酸序列形成的异常结构。已经假定G-四链体在许多生物系统中起重要作用，包括基因调控和酶功能抑制。最近，我们的实验室报道了合成并评价具有良好亲和性和选择性的G-四链体的Triaza-cyclopentaphenanthrene化合物的合成和评价。该化合物含有一个4-吡啶酮基团，该基团以前没有用于其他四链体结合剂中。在这封信中，我们描述了含有2-和3-羧基-苯并喹啉作为G-四链体结合剂的4-吡啶酮的合成和评价。我们发现这些化合物能够与K a在3×10 5范围内的G-四链体结合。 M -1且对四链体的选择性是双链体DNA的10倍。
• Evaluation of 3-Carboxy-4(1<i>H</i>)-quinolones as Inhibitors of Human Protein Kinase CK2
  作者：Andriy G. Golub、Olexander Ya. Yakovenko、Volodymyr G. Bdzhola、Vladislav M. Sapelkin、Piotr Zien、Sergiy M. Yarmoluk

  DOI：10.1021/jm050048t

  日期：2006.11.1

  Due to the emerging role of protein kinase CK2 as a molecule that participates not only in the development of some cancers but also in viral infections and inflammatory failures, small organic inhibitors of CK2, besides application in scientific research, may have therapeutic significance. In this paper, we present a new class of CK2 inhibitorss3-carboxy-4(1H)-quinolones. This class of inhibitors has been selected via receptor-based virtual screening of the Otava compound library. It was revealed that the most active compounds, 5,6,8-trichloro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (7) (IC50 = 0.3 mu M) and 4-oxo-1,4-dihydrobenzo[h] quinoline-3-carboxylic acid (9) (IC50 = 1 AM), are ATP competitive (K-i values are 0.06 and 0.28 mu M, respectively). Evaluation of the inhibitors on seven protein kinases shows considerable selectivity toward CK2. According to theoretical calculations and experimental data, a structural model describing the key features of 3-carboxy-4(1H)-quinolones responsible for tight binding to CK2 active site has been developed.
• Duffin; Kendall, Journal of the Chemical Society, 1948, p. 893
  作者：Duffin、Kendall

  DOI：——

  日期：——
• HEME OXYGENASE INHIBITORS, SCREENING METHODS FOR HEME OXYGENASE INHIBITORS AND METHODS OF USE OF HEME OXYGENASE INHIBITORS FOR ANTIMICROBIAL THERAPY
  申请人：Wilks Angela

  公开号：US20100081661A1

  公开（公告）日：2010-04-01

  Inhibitors of microbial heme oxygenase and their use for treatment of microbial infections and bioremediation. The inhibitors of microbial heme oxygenase are useful against a new class of antimicrobial agents to target infections that are persistently difficult to combat with the current spectrum of antimicrobial agents. Screening methods for selecting inhibitors of microbial heme oxygenase.